Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study evaluating rituximab for safety and efficacy in adults with primary progressive multiple sclerosis has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Rituximab (Rituxan) (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-09-09